| Literature DB >> 19036134 |
Françoise Jaureguy1, Luce Landraud, Virginie Passet, Laure Diancourt, Eric Frapy, Ghislaine Guigon, Etienne Carbonnelle, Olivier Lortholary, Olivier Clermont, Erick Denamur, Bertrand Picard, Xavier Nassif, Sylvain Brisse.
Abstract
BACKGROUND: Extraintestinal pathogenic Escherichia coli (ExPEC) strains represent a huge public health burden. Knowledge of their clonal diversity and of the association of clones with genomic content and clinical features is a prerequisite to recognize strains with a high invasive potential. In order to provide an unbiased view of the diversity of E. coli strains responsible for bacteremia, we studied 161 consecutive isolates from patients with positive blood culture obtained during one year in two French university hospitals. We collected precise clinical information, multilocus sequence typing (MLST) data and virulence gene content for all isolates. A subset representative of the clonal diversity was subjected to comparative genomic hybridization (CGH) using 2,324 amplicons from the flexible gene pool of E. coli.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19036134 PMCID: PMC2639426 DOI: 10.1186/1471-2164-9-560
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Nucleotide polymorphism found in the eight housekeeping genes used for MLST
| Gene | Template size | No. of alleles | No. (%) of polymorphic sites | Ks | Ka | Ka/Ks | π |
| 450 | 30 | 59 (13.1) | 0.124 | 0.00197 | 0.0159 | 0.0297 | |
| 516 | 45 | 52 (10.1) | 0.093 | 0.0004 | 0.0043 | 0.0273 | |
| 468 | 32 | 44 (9.4) | 0.075 | 0.00763 | 0.102 | 0.0226 | |
| 450 | 36 | 65 (14.4) | 0.124 | 0.00301 | 0.024 | 0.0287 | |
| 456 | 25 | 43 (9.4) | 0.067 | 0.0015 | 0.0225 | 0.0174 | |
| 561 | 33 | 87 (15.5) | 0.156 | 0.00537 | 0.0345 | 0.0393 | |
| 594 | 25 | 65 (10.9) | 0.133 | 0.00198 | 0.0149 | 0.0299 | |
| 600 | 27 | 56 (9.3) | 0.074 | 0.003 | 0.0408 | 0.0183 |
Ks: No. of synonymous changes per synonymous site. Ka: No. of non-synonymous changes per non-synonymous site.
π: nucleotide diversity.
Figure 1Phylogenetic diversity. Phylogenetic analysis performed using ClonalFrame based on the sequence of eight protein-coding genes (4,095 nt in total), of 161 Escherichia coli isolates from bacteremia (circles), 67 ECOR strains (open squares) and seven genome reference strains (triangles). Color of strain symbols is according to triplex-PCR grouping into major phylogenetic groups (red, B2; green, B1; yellow, D; blue, A).
Figure 2Cluster analysis of . (A) Minimum spanning tree analysis of the 161 E. coli isolates based on allelic profiles at the eight genes dinB, icdA, pabB, polB, putP, trpA, trpB and uidA. Each circle corresponds to a sequence type (the ST number is given inside the circle), and the size of the circle is related to the number of isolates found with that profile (from 1 for small circles e.g. ST14 to 17 for ST4). Grey zones between some groups of circles indicate that these profiles belong to the same clonal complex (CC). Circles were colored based on triplex-PCR phylogroup assignment. Bold, plain and discontinuous links between circles correspond to one, two or more allelic mismatch(es), respectively; note that links with distance > 2 are not reliable (for example, the spread of group D across the entire graph does not indicate discrepancy of MLST with triplex PCR). Grey roman numbers above some CCs correspond to B2 subgroups as defined in a previous study [21]. The position of strain APEC O1 was added manually; it corresponds to a single locus variant of ST1. (B) Classification of 60 bacteremic isolates using macroarray analysis results. Reference strains are indicated by black arrows on the right. Note that two apparently misplaced isolates (NCK023 and NCK016) belong to groups B2 and E, respectively, based on MLST genes.
Relationships between clinical determinants and the 11 major clonal complexes
| A | B2 | D | ||||||||||
| All | CC2 | CC66 | CC1 | CC4 | CC36 | CC6 | CC32 | CC10 | CC40 | CC43 | CC3 | |
| Age ≥ 65 years old | 82 | 5 | 7 | 9 | 6 | 3 | 3 | 2 | 4 | 3 | 3 | 6 |
| Male gender | 84 | 8 | 4 | 10 | 8 | 0** | 3 | 6** | 4 | 4 | 1 | 5 |
| Diabetes mellitus | 33 | 2 | 2 | 5 | 1 | 1 | 3* | 1 | 1 | 1 | 1 | 1 |
| Neoplasia | 30 | 5* | 3 | 3 | 1 | 2 | 0 | 1 | 2 | 2 | 0 | 2 |
| Hematological malignancy | 32 | 1 | 3 | 3 | 2 | 2 | 2 | 0 | 2 | 0 | 1 | 4 |
| HIV infection | 5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Renal failure | 33 | 1 | 5** | 1 | 5 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
| Immune status | ||||||||||||
| Immunocompetent | 102 | 7 | 7 | 14 | 10 | 3 | 3 | 5 | 6 | 7** | 2 | 4 |
| Immunocompromised | 59 | 6 | 4 | 3 | 7 | 4 | 2 | 1 | 2 | 0 | 3 | 6 |
| Origin of infection | ||||||||||||
| Community-acquired | 99 | 7 | 6 | 12 | 12 | 4 | 3 | 4 | 6 | 5 | 2 | 5 |
| Nosocomial | 62 | 6 | 5 | 5 | 5 | 3 | 2 | 2 | 2 | 2 | 3 | 5 |
| Source of bacteremia | ||||||||||||
| Urinary tract | 66 | 4 | 3 | 12** | 11** | 4 | 2 | 0* | 4 | 3 | 1 | 1** |
| Digestive tract | 59 | 7 | 4 | 5 | 3 | 2 | 3 | 2 | 2 | 1 | 3 | 7** |
| Others and unknown | 36 | 2 | 4 | 0** | 3 | 1 | 0 | 4** | 2 | 3 | 1 | 2 |
| Sepsis stage | ||||||||||||
| Sepsis | 131 | 12 | 9 | 15 | 13 | 7 | 5 | 4 | 8 | 4 | 4 | 6 |
| Severe sepsis | 12 | 1 | 0 | 0 | 2 | 0 | 0 | 1 | 0 | 2 | 1 | 1 |
| Septic shock | 18 | 0 | 2 | 2 | 2 | 0 | 0 | 1 | 0 | 1 | 0 | 3 |
| Died | 16 | 0 | 0 | 1 | 1 | 1 | 0 | 2 | 0 | 2 | 1 | 2 |
Data are displayed as number of isolates. CC: clonal complex.
* p < 0.1 for considered CC vs. all other isolates.
** p < 0.05 for considered CC vs. all other isolates.
Virulence factor content of the 11 major clonal complexes
| A | B2 | D | ||||||||||||
| Bacterial determinants | All | All | CC2 | CC66 | All | CC1 | CC4 | CC36 | CC6 | CC32 | CC10 | CC40 | CC43 | CC3 |
| papC | 79 | 9 | 4 | 3 | 60 | 15* | 13* | 7* | 2 | 5* | 8* | 5 | 1** | 3 |
| papG II | 47 | 2 | 1 | 0* | 36 | 15* | 12* | 4 | 2 | 0** | 0** | 0** | 1 | 3 |
| papG III | 27 | 0 | 0 | 0 | 27 | 0 | 4 | 3§ | 0 | 5* | 7* | 5* | 0 | 0 |
| Sfa | 47 | 1 | 0* | 1 | 46 | 2** | 16* | 7* | 1 | 4§ | 8* | 5* | 0** | 0* |
| hlyC | 51 | 2 | 0* | 1 | 48 | 3** | 15* | 7* | 0** | 5* | 7* | 7* | 1 | 0* |
| cnf1 | 48 | 1 | 0* | 1 | 47 | 2§** | 15* | 7* | 0** | 5* | 8* | 7* | 0** | 0* |
| iucC | 106 | 23 | 9 | 10§ | 52 | 15§** | 15§** | 5 | 5 | 1* | 0* | 3 | 4 | 7 |
| iron | 93 | 15 | 4§ | 7 | 63 | 15* | 16* | 7* | 1** | 4 | 8* | 7* | 1** | 3§ |
| fyuA | 125 | 19 | 8 | 8 | 80 | 17* | 17* | 7 | 5 | 6 | 8 | 7 | 5 | 4* |
Data are displayed as number of isolates. CC, clonal complex; papC, P fimbriae; papGII, adhesin PapG class II; papGIII, adhesin PapG class III; sfa, S fimbriae; hlyC, hemolysinC; cnf1, cytotoxic necrotizing factor; iucC, iron uptake system (IUS) aerobactin; fyuA, IUS yersiniabactin; iroN, IUS salmochelin.
§p < 0.1 for considered CC vs. all other isolates.
* p < 0.05 for considered CC vs. all other isolates.
** p < 0.05 for considered CC vs. all other B2 isolates.
Figure 3Open reading frames that distinguish the two clonal complexes CC1 and CC4 from other . Pattern of presence (yellow) or absence (blue) of ORFs, which presence was positively (A) or negatively (B) associated with B2 isolates of CC1 and/or CC4 isolates, as compared with non-CC1, non-CC4 B2 isolates. Each row corresponds to one ORF; columns represent the 26 assayed B2 isolates grouped by clonal complex. Blue: absent; yellow: present; black: inconclusive. Note that ORFs are clustered vertically using software TMeV based on their pattern of presence among isolates. Five groups can be distinguished based on presence/absence in CC1 and/or CC4, as commented on the right. In panel A), colored squares on the right indicate that ORFs belong to genomic clusters (see text), as indicated.
Primers used for MLST
| Locus | Function | Forward primer | Reverse primer | Location (a) |
| DNA polymerase | 5'-GTT TTC CCA GTC ACG ACG TTG TAT GAG AGG TGA GCA ATG CGT A-3' | 5'-TTG TGA GCG GAT AAC AAT TTC CGT AGC CCC ATC GCT TCC AG-3' | 282,284 – 282,734 | |
| Isocitrate dehydrogenase | 5'-GTT TTC CCA GTC ACG ACG TTG TAA TTC GCT TCC CGG AAC ATT G-3' | 5'-TTG TGA GCG GAT AAC AAT TTC ATG ATC GCG TCA CCA AAY TC-3' | 1,118,658 – 1,187,173 | |
| p-aminobenzoate synthase | 5'-GTT TTC CCA GTC ACG ACG TTG TAA ATC CAA TAT GAC CCG CGA G-3' | 5'-TTG TGA GCG GAT AAC AAT TTC GGT TCC AGT TCG TCG ATA AT-3' | 1,807,273 – 1,807,740 | |
| Polymerase PolII | 5'-GTT TTC CCA GTC ACG ACG TTG TAG GCG GCT ATG TGA TGG ATT C-3' | 5'-TTG TGA GCG GAT AAC AAT TTC GGT TGG CAT CAG AAA ACG GC-3' | 65,220 – 64, 773 | |
| Proline permease | 5'-GTT TTC CCA GTC ACG ACG TTG TAC TGT TTA ACC CGT GGA TTG C-3' | 5'-TTG TGA GCG GAT AAC AAT TTC GCA TCG GCC TCG GCA AAG CG-3' | 1,074,708 – 1,075,163 | |
| Tryptophan synthase subunit A | 5'-GTT TTC CCA GTC ACG ACG TTG TAG CTA CGA ATC TCT GTT TGC C-3' | 5'-TTG TGA GCG GAT AAC AAT TTC GCT TTC ATC GGT TGT ACA AA-3' | 1,338,658 – 1,338,098 | |
| Tryptophan synthase subunit B | 5'-GTT TTC CCA GTC ACG ACG TTG TAC ACT ATA TGC TGG GCA CCG C-3' | 5'-TTG TGA GCG GAT AAC AAT TTC CCT CGT GCT TTC AAA ATA TC-3' | 1,339,430 – 1,338,837 | |
| Beta-glucuronidase | 5'-GTT TTC CCA GTC ACG ACG TTG TAC ATT ACG GCA AAG TGT GGG TCA AT-3' | 5'-TTG TGA GCG GAT AAC AAT TTC CCA TCA GCA CGT TAT CGA ATC CTT-3' | 1,615,010 – 1,614,411 | |
| OF | Sequencing primer (b) | 5'-GTT TTC CCA GTC ACG ACG TTG T-3' | ||
| OR | Sequencing primer (b) | 5'-TTG TGA GCG GAT AAC AAT TTC-3' |
(a) Based on Escherichia coli strain 536, complete genome, GenBank accession CP000247.
(b) PCR primers have the corresponding universal sequence in 5'.